Delivery Order SPE2DB20D3101-SPE2DB25FQZU6
Award Date
1/23/25
Potential Completion Date
1/24/25
Potential Value
$3.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,679.87 delivery order contract is for the supply of CATHFLO ACTIVASE 2 MG VIALS, a pharmaceutical product. The award is not set aside and is a firm fixed-price contract type with a performance period ending on May 15, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
The federal contract award is for the delivery of CATHFLO ACTIVASE 2 MG VIALS to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $2,070.45 and is a firm fixed price delivery order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set aside and was awarded on May 19, 2025, with a completion date of May 20, 2025. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,545.12 firm fixed-price delivery order is for the supply of CATHFLO ACTIVASE 2 MG VIALS, a critical pharmaceutical product. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which serves as a...
This federal contract award, with ID SPE2DB25D3012|SPE2DB25FWWVS, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CATHFLO ACTIVASE 2 MG VIALS, a medical product, with a ceiling value of $1,401.58. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of April 16, 2025. This award is not associated with any...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order with a firm fixed price of $3,393.60 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CATHFLO ACTIVASE 2 MG VIALS, a medical product, with a period of performance through January 24, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support...
This federal contract award, valued at $78,297.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of CATHFLO ACTIVASE 2 MG VIALS, a pharmaceutical product. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, with ID SPE2DB22D3501|SPE2DB25FVE29, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp for the delivery of CATHFLO ACTIVASE 2 MG VIALS. The contract has a ceiling value of $6,128.50 and an ultimate completion date of April 8, 2025. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation indicated. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
This federal contract award, valued at $21,655.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of CATHFLO ACTIVASE 2 MG VIALS, a critical medical product, with an ultimate completion date of October 29, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, with ID SPE2DB22D3301|SPE2DB25FX4CM, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $3,212.70, is a delivery order for the supply of 4,566,174,150 units of CATHFLO ACTIVASE 2 MG VIALS. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,427.39 Firm Fixed Price Delivery Order is for the supply of CATHFLO ACTIVASE 2 MG VIALS, a critical medical product, with a period of performance through December 17, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...